News

How consumers’ digital activity trackers could enable personalized health screening and early intervention for cardiovascular health and beyond.

Study will investigate whether a GIP/GLP-1 dual receptor agonist, currently approved for type 2 diabetes, obesity and obstructive sleep apnea, can reduce symptoms of long COVID.

Scripps Research scientists reveal how wearable sensors and artificial intelligence could transform the way we detect and manage pre-diabetes.

Researchers show that mpox circulated among humans in Nigeria for eight years before the international outbreak, highlighting the need for improved surveillance.

Latest book by Scripps Research executive vice president guides readers through medical breakthroughs that are primed to extend healthspan

An international collaboration between Scripps Research, University of Arizona, CNRS and others provides additional analysis of how the pandemic began.

Scripps Research scientists showed that, with help from an AI tool, cardiologists can diagnose heart attacks using a simpler, easier and more accessible electrocardiogram technology.

Wearable health sensors are a powerful tool in disease detection and in stemming the spread of infections.

Scripps Research launches digital trial to identify sleep-related risk factors for Alzheimer’s disease and other dementias using activity trackers.

New list honors 100 individuals who most influenced global health in 2024.

Topol provides an overview of how AI models can improve diagnostic accuracy, liberate clinicians from keyboards and restore the doctor-patient relationship.

Bill & Melinda Gates Foundation award to support the development of multi-pathogen wastewater surveillance tools and protocols.

The award renews support for Scripps Research Translational Institute and partner organizations involved in expanding one of the largest and most inclusive health data resources of its kind.

The Translational Institute is harnessing genomic and digital technologies with machine learning to revolutionize health research.

Grant renewal from the NIH-NIAID will help uncover critical information about the viruses that cause COVID-19, Lassa and Ebola, including how they evolve.  

Preliminary results from a Scripps Research and eMed digital medicine study show an unexpectedly high proportion of COVID-19 rebound cases in untreated people, as well as those treated with Paxlovid.

In partnership with Cue Health, the study will deploy at-home COVID-19 tests, on-demand telemedicine and delivery of antiviral medication in an effort to lessen severe disease outcomes.

Work will include fast analyses of virus transmission in the San Diego area and across the U.S.- Mexico border.

New analysis finds that climate change and other factors could soon make deadly Lassa fever a much bigger public health problem in Africa

Findings highlight biases in viral sampling and urgent need for better global health infrastructure.

Analyses based on locations and viral sequencing of early cases suggest pandemic started in Wuhan’s Huanan market, with two separate jumps from animals to humans.

New tools developed at Scripps Research and UC San Diego are helping public health officials around the world get vital information about pathogen variants from wastewater.

Scripps Research scientists find digital biomarkers that could be associated with vaccine-induced immune response.

Study showed that at-risk users who downloaded the app increased life-saving statin use.